Bessemer Group
HOLX

Bessemer Group’s Hologic HOLX Stock Holding History

Bessemer Group’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,464
Closed -$790K – 2568
2026
Q1 		$790K Buy
10,464
+816
+8% +$61.4K ﹤0.01% 1004
2025
Q4 		$718K Sell
9,648
-3,769
-28% -$275K ﹤0.01% 1042
2025
Q3 		$906K Buy
13,417
+32
+0.2% +$2.12K ﹤0.01% 676
2025
Q2 		$872K Sell
13,385
-7,561
-36% -$453K ﹤0.01% 665
2025
Q1 		$1.29M Sell
20,946
-27,711
-57% -$1.84M ﹤0.01% 599
2024
Q4 		$3.51M Sell
48,657
-485
-1% -$37.9K 0.01% 510
2024
Q3 		$4M Buy
49,142
+38,581
+365% +$3.09M 0.01% 483
2024
Q2 		$784K Sell
10,561
-331
-3% -$24.8K ﹤0.01% 716
2024
Q1 		$848K Buy
10,892
+809
+8% +$60.2K ﹤0.01% 696
2023
Q4 		$720K Buy
10,083
+444
+5% +$30.9K ﹤0.01% 728
2023
Q3 		$669K Sell
9,639
-4,065
-30% -$307K ﹤0.01% 724
2023
Q2 		$1.11M Buy
13,704
+3,895
+40% +$318K ﹤0.01% 611
2023
Q1 		$792K Sell
9,809
-303
-3% -$24.4K ﹤0.01% 632
2022
Q4 		$757K Sell
10,112
-700
-6% -$49.8K ﹤0.01% 633
2022
Q3 		$697K Buy
10,812
+8,499
+367% +$589K ﹤0.01% 652
2022
Q2 		$160K Sell
2,313
-50
-2% -$3.71K ﹤0.01% 927
2022
Q1 		$182K Buy
2,363
+289
+14% +$20.8K ﹤0.01% 846
2021
Q4 		$158K Buy
2,074
+156
+8% +$11.5K ﹤0.01% 903
2021
Q3 		$142K Buy
1,918
+187
+11% +$14K ﹤0.01% 861
2021
Q2 		$116K Sell
1,731
-51
-3% -$3.41K ﹤0.01% 921
2021
Q1 		$132K Buy
1,782
+358
+25% +$27.2K ﹤0.01% 845
2020
Q4 		$103K Buy
1,424
+161
+13% +$11.4K ﹤0.01% 860
2020
Q3 		$84K Hold
1,263
– – ﹤0.01% 868
2020
Q2 		$72K Buy
1,263
+1,102
+684% +$54.1K ﹤0.01% 1290
2020
Q1 		$6K Sell
161
-176
-52% -$8.38K ﹤0.01% 1485
2019
Q4 		$18K Hold
337
– – ﹤0.01% 1381
2019
Q3 		$17K Sell
337
-1,500
-82% -$73.8K ﹤0.01% 1421
2019
Q2 		$88K Sell
1,837
-605
-25% -$28K ﹤0.01% 1225
2019
Q1 		$118K Sell
2,442
-1,092
-31% -$49.2K ﹤0.01% 1105
2018
Q4 		$145K Hold
3,534
– – ﹤0.01% 1062
2018
Q3 		$145K Buy
3,534
+1,945
+122% +$78.6K ﹤0.01% 1048
2018
Q2 		$63K Buy
1,589
+37
+2% +$1.42K ﹤0.01% 1206
2018
Q1 		$58K Hold
1,552
– – ﹤0.01% 1217
2017
Q4 		$66K Sell
1,552
-393
-20% -$15.7K ﹤0.01% 1211
2017
Q3 		$71K Buy
1,945
+82
+4% +$3.31K ﹤0.01% 1242
2017
Q2 		$84K Buy
1,863
+363
+24% +$16K ﹤0.01% 1211
2017
Q1 		$64K Sell
1,500
-558
-27% -$22.7K ﹤0.01% 1262
2016
Q4 		$83K Buy
2,058
+558
+37% +$21.5K ﹤0.01% 1256
2016
Q3 		$58K Hold
1,500
– – ﹤0.01% 1182
2016
Q2 		$52K Hold
1,500
– – ﹤0.01% 857
2016
Q1 		$52K Hold
1,500
– – ﹤0.01% 897
2015
Q4 		$58K Sell
1,500
-55
-4% -$2.14K ﹤0.01% 937
2015
Q3 		$61K Buy
1,555
+55
+4% +$2.18K ﹤0.01% 925
2015
Q2 		$57K Hold
1,500
– – ﹤0.01% 946
2015
Q1 		$50K Buy
+1,500
New +$46K ﹤0.01% 970
2014
Q3 		– Sell
-88
Closed -$2K – 1304
2014
Q2 		$2K Buy
+88
New +$2.06K ﹤0.01% 1276
2013
Q4 		– Sell
-169
Closed -$3K – 1358
2013
Q3 		$3K Buy
+169
New +$3.6K ﹤0.01% 1167

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bessemer Group's HOLX Position: Q2 2026 in Review

Bessemer Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 10,464 shares — an estimated $790K sold.

Bessemer Group first reported a position in HOLX in Q3 2013 and held it in 47 quarters. The position peaked at $4M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Bessemer Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Bessemer Group sold 10,464 Hologic shares in Q2 2026, an estimated $790K.
  • Bessemer Group first reported a position in Hologic in Q3 2013 and held it in 47 quarters.
  • Bessemer Group's Hologic position peaked at $4M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.